Home  >  Events  >  SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference, October 28 – 29, 2020 Sheraton Boston Hotel, Boston, MA, USA
SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference,  October 28 – 29, 2020 Sheraton Boston Hotel, Boston, MA, USA

SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference, October 28 – 29, 2020 Sheraton Boston Hotel, Boston, MA, USA

Supplier: SMi Group

Description

SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA, Microcoat, Millipore Sigma

CHAIRED BY: Lynne Ensor,VP Technical, Parexel

Exploring the current approaches towards improved contamination control

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss the revision of Annex 1, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring and gain insight into an industry perspective on automated endotoxin testing and process automation.

Event Hashtag: #SMiPharmaMicroEC

HIGHLIGHTS FOR 2020:
•    Discuss ongoing complication of personnel derived contaminations from the FDA
•    Gain valuable insight towards microbiological quality considerations in non-sterile manufacturing and control of BCC from Parexel
•    Learn from the perspective of the US Pharmacopeia on container closure integrity evaluation
•    Examine an end-to-end contamination risk assessment for autologous cell therapy from Juno Therapeutics
•    Explore a back to back Genentech session covering technical considerations for microbial QC of raw materials used in biotechnology and the past, current and future state of Mycoplasma testing

Post-Conference Workshop – May 1, 2020
The Use of Recombinant Chromogenic Assays as Alternate Methods for the Bacterial Endotoxins Test (BET)
Workshop Leader:
Veronika Wills, Manager, Technical Services, Associates of Cape Cod

View the full agenda: www.microbiologyeastcoast.com/absaveWL  

WHO SHOULD ATTEND
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist, Drug Substance External Manufacturer, QC Scientists, Heads of Quality, Business Development Manager, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist

EARLY BIRD-RATES
•    BOOK BY 31ST JANUARY AND SAVE US$300
•    BOOK BY 28TH FEBRUARY AND SAVE US$100
Button_on Button_off_labsave Button_off_labsave Button_off_labsave